Skip to content

Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients

Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04744896
Enrollment
90
Registered
2021-02-09
Start date
2021-03-01
Completion date
2022-02-28
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperinsulinism, Polycystic Ovary Syndrome

Keywords

pco

Brief summary

this study will be carried to investigate the effect of cryolipolysis and high intensity interval training on insulin resistance and body composition in pco women

Detailed description

This study will be carried out on ninety females with polycystic ovarian syndrome (PCOS)l. Their age ranges from 17-28 years, body mass index 25-30 Kg/m2. They experience hyperandrogenism and hyperinsulinemia. PCOS females will be randomly assigned into three equal groups: group (A) consists of 30 women who receive cryolipolysis and group (B) consists of 30 women who receive high intensity interval training and group (C) receive both

Interventions

DEVICEcryolipolysis(3 max cool shaping)

cryolioplysis applied over abdomen area

DEVICETreadmill (jkexer focus 8020A)

aerobic training ( high intensity interval training)

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

cryolipolysis treadmill cryolipolysis + treadmill

Eligibility

Sex/Gender
FEMALE
Age
17 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* women diagnosed with polycystic ovarian syndrome * age ranges from 17-28 years * body mass index ranges 25-30 Kg/m2

Exclusion criteria

* Diabetic patients. * Women with BMI\>30 * Women having circulatory dysfunction. * Women with respiratory or cardiac disease * liver disease. * Skin disease . * Previous abdominal or uterine surgery * any medications affecting hormones * any physical impairments * Physical impairment

Design outcomes

Primary

MeasureTime frameDescription
HOMA IR3 monthsblood test
weightup to 3 monthsanthropometric measure measured in kilogram (kg)
fat percentageup to 3 monthsoverall body fat percentage measured by body fat analyzer in percentage (%)

Secondary

MeasureTime frameDescription
waist circumferenceup to 3 monthsanthropometric measurement measured in centimeter (cm)

Countries

Egypt

Contacts

Primary Contactmiral saleh, md
marmooramido@gmail.com01200678845

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026